These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2157601)

  • 21. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice.
    Nakazawa T; Furuya Y; Kaneko T; Yamatsu K
    J Pharmacol Exp Ther; 1991 Jan; 256(1):76-81. PubMed ID: 1671100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic opioid antagonist treatment increases mu and delta receptor mediated spinal opioid analgesia.
    Yoburn BC; Paul D; Azimuddin S; Lutfy K; Sierra V
    Brain Res; 1989 Apr; 485(1):176-8. PubMed ID: 2541864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mu antagonist and kappa agonist properties of b-funaltrexamine (b-FNA): long lasting spinal antinociception.
    Jiang Q; Heyman JS; Porreca F
    NIDA Res Monogr; 1989; 95():199-205. PubMed ID: 2561827
    [No Abstract]   [Full Text] [Related]  

  • 25. Spinal delta 2-, but not delta 1-, mu-, or kappa-opioid receptors are involved in the tail-flick inhibition induced by beta-endorphin from nucleus raphe obscurus in the pentobarbital-anesthetized rat.
    Tseng LF; Tsai JH; Collins KA; Portoghese PS
    Eur J Pharmacol; 1995 Apr; 277(2-3):251-6. PubMed ID: 7493616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delta opiate receptors mediate tail-shock induced antinociception at supraspinal levels.
    Watkins LR; Wiertelak EP; Maier SF
    Brain Res; 1992 Jun; 582(1):10-21. PubMed ID: 1323369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels.
    Watkins LR; Wiertelak EP; Maier SF
    Brain Res; 1992 Jun; 582(1):1-9. PubMed ID: 1354010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of spinal kappa opioid receptors in a type of footshock induced analgesia in mice.
    Menendez L; Andres-Trelles F; Hidalgo A; Baamonde A
    Brain Res; 1993 May; 611(2):264-71. PubMed ID: 8392894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic selective blockade of mu opioid receptors produces analgesia and augmentation of the effects of a kappa agonist.
    Walker MJ; Lê AD; Poulos CX; Cappell H
    Brain Res; 1991 Jan; 538(2):181-6. PubMed ID: 1849435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists.
    Murray CW; Cowan A
    J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
    Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
    Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
    Miaskowski C; Levine JD
    Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
    Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
    Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of the antinociceptive effect of nitrous oxide by inhibition of enzyme activity or expression of neuronal nitric oxide synthase in the mouse brain and spinal cord.
    Cope JL; Chung E; Ohgami Y; Quock RM
    Eur J Pharmacol; 2010 Jan; 626(2-3):234-8. PubMed ID: 19818753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
    Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
    Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
    Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
    Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of subtype-selective opioid receptor blockers on nitrous oxide antinociception in rats.
    Quock RM; Walczak CK; Henry RJ; Chen DC
    Pharmacol Res; 1990; 22(3):351-7. PubMed ID: 2164191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice.
    Kamei J; Kashiwazaki T; Hitosugi H; Nagase H
    Eur J Pharmacol; 1997 May; 326(1):31-6. PubMed ID: 9178652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.